Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

COPD is a serious yet preventable disease, and early intervention can preserve lung function and overall well-being.

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

(HealthDay News) — Beginning cigarette smoking before 15 years of age is significantly associated with later chronic ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...